Skip to main content

MiCort HC Cream

Generic: Hydrocortisone Acetate Cream

Verified·Apr 23, 2026
Manufacturer
PruGen
NDC
83107-026
Route
TOPICAL
ICD-10 indication
L30.9

Affordability Check

How much will you actually pay for MiCort HC Cream?

In 30 seconds, see every legitimate way to afford MiCort HC Cream — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About MiCort HC Cream

What is this medication? MiCort HC Cream is a prescription topical corticosteroid that contains hydrocortisone acetate as its active ingredient. This medication is primarily used to treat the inflammation, swelling, and itching associated with a wide variety of skin conditions. It works by depressing the formation and release of substances in the body that cause inflammation. By applying the cream directly to the skin, it helps to soothe irritation and provides relief from redness and physical discomfort caused by the immune system's response to an irritant or underlying condition.

Physicians typically prescribe this medication for the management of skin issues such as eczema, dermatitis, and allergic reactions. It is also effective for treating rashes caused by contact with certain plants, like poison ivy or oak, as well as irritation from insect bites. Because this formulation contains a higher concentration of hydrocortisone than many over-the-counter options, it is often used when milder treatments have not been successful. Patients are generally advised to apply a thin layer to the affected area and to follow specific instructions regarding the duration of treatment to avoid potential side effects.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for MiCort HC Cream. Official source: DailyMed (NLM) · Label effective Jul 28, 2025

Indications and usage
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and administration
DOSAGE AND ADMINISTRATION Topical corticosteroids are generally applied to the affected areas as a thin film two to four times daily depending on the severity of the condition. Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the used of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Contraindications
CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressing. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions hypopigmentation, period dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
Use in pregnancy
Pregnancy - Teratogenic Effects Pregnancy Category C: Corticosteroids are generally teratogenic in laboratory animals when administered systemically are relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic cffects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged period of time.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.